A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor
- 1 April 1981
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 28 (14), 1641-1646
- https://doi.org/10.1016/0024-3205(81)90320-9
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Experimental Studies of Trapidil on Thromboxane A2 (TXA2)-induced Aggregation of Platelets, Ischemic Changes in Heart and Synthesis of TXA2The Journal of Japan Atherosclerosis Society, 1979
- Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells.Circulation Research, 1978
- Hyperlipidemia and AtherosclerosisScience, 1976
- The Pathogenesis of AtherosclerosisNew England Journal of Medicine, 1976
- The Pathogenesis of AtherosclerosisNew England Journal of Medicine, 1976
- Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate.The Journal of cell biology, 1976
- A platelet factor stimulating human normal glial cellsExperimental Cell Research, 1976
- Platelets as a source of fibroblast growth-promoting activityExperimental Cell Research, 1974
- Atherosclerosis and the Arterial Smooth Muscle CellScience, 1973